113 - POLYCLONAL Vβ21.3 EXPANSION IN POST-VACCINATION MULTISYSTEM INFLAMMATORY SYNDROME IN CHILDREN
Location: St-Laurent
Author: Stejara A. Netea, n/a – Pediatric Hematology-Immunology-infectious diseases, Emma Children's Hospital, Amsterdam, Netherlands
2:40 PM – 3:00 PM East Coast USA Time
116 - FOUR GRAND-PARENTS ETHNIC ORIGIN OF KD AND MIS-C PATIENTS. THE MONTRÉAL OBSERVATION DURING THE SARS-COV-2 PANDEMIC
Location: St-Laurent
Author: Joe Abou Abdallah, n/a – division of Pediatric Cardiology, CHU Sainte-Justine, University of Montreal, Canada
2:40 PM – 3:00 PM East Coast USA Time
118 - INCREASED OXIDATIVE STRESS MARKERS (NITRIC OXIDE, REACTIVE OXYGEN SPECIES) INDUCE ENDOTHELIAL DYSFUNCTION IN KAWASAKI DISEASE PATIENTS ON FOLLOW-UP- THE FIRST STUDY FROM THE INDIAN SUBCONTINENT
Location: St-Laurent
Author: RAJNI KUMRAH, PhD – Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India
2:40 PM – 3:00 PM East Coast USA Time
127 - EVALUATION OF MARKERS OF ENDOTHELIAL DYSFUNCTION IN PATIENTS WITH KAWASAKI DISEASE ON FOLLOW-UP USING FLOWCYTOMETRY, TRANSCRIPTOMICS AND PROTEOMICS- THE FIRST SUCH STUDY FROM THE INDIAN SUBCONTINEN
Location: Poster hall
Author: RAJNI KUMRAH, PhD – Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India
2:40 PM – 3:00 PM East Coast USA Time
128 - LONG-TERM PROGNOSIS OF KAWASAKI DISEASE: PREVIOUS FINDINGS AND INTERIM ANALYSIS OF THE PROSPECTIVE COHORT STUDY
Location: St-Laurent
Author: Koki Kosami, M.D. – Division of Public Health, Center for Community Medicine, Jichi Medical University
2:40 PM – 3:00 PM East Coast USA Time
143 - IMMUNE CHECKPOINT MOLECULE PROGRAMMED DEATH-LIGAND 1 EXPRESSION IN KAWASAKI DISEASE: A PILOT STUDY FROM CHANDIGARH, NORTH INDIA
Location: St-Laurent
Author: PALLAVI L. NADIG, MD – ALLERGY IMMUNOLOGY UNIT, ADVANCED PEDIATRICS CENTER, POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH
2:40 PM – 3:00 PM East Coast USA Time
148 - CAN VARIABILITY IN THE WIND EXPLAIN EPIDEMIOLOGICAL FEATURES OF KAWASAKI DISEASE IN JAPAN?
161 - UNRAVELLING THE INFLAMMASOME CASCADE IN KD PATHOGENESIS: AN ARENA THAT HAS REMAINED UNEXPLORED SO FAR
Author: DEEPTI SURI, MD – Post graduate institute of medical education and research
Immunology
2:40 PM – 3:00 PM East Coast USA Time
173 - EPIDEMIOLOGICAL SHIFTS IN KAWASAKI DISEASE INCIDENCE DURING AND AFTER THE COVID-19 PANDEMIC: OBSERVATIONS FROM CHANDIGARH, NORTH INDIA, DURING THE PERIOD JANUARY 2020- DECEMBER 2023
200 - ANTIBODIES TARGETING HIV GP41 IDENTIFY PEPTIDES WITH SIMILARITY TO PROPOSED KAWASAKI DISEASE RELATED PEPTIDE, SUGGESTING NON-SPECIFIC MIMOTOPE TARGETING BY ACIDIC AMINO ACID ENRICHED REGIONS
Author: MARK D. HICAR, MD/PhD – Jacobs School of Medicine and Biomedical Sciences, University at Buffalo
2:40 PM – 3:00 PM East Coast USA Time
202 - INVESTIGATION OF PATIENT ETHNIC ORIGINS UNVEILS NEW INSIGHTS INTO THE EPIDEMIOLOGY OF KAWASAKI DISEASE IN THE PROVINCE OF QUEBEC, CANADA
23 - EFFICACY OF ANGIOTENSIN II RECEPTOR BLOCKER/ANGIOTENSIN CONVERTING ENZYME FOR CORONARY ARTERY ANEURYSM REGRESSION IN JAPANESE PATIENT WITH KAWASAKI DISEASE
Location: Outremont
Author: Eisuke Suganuma, M.D., Ph.D. – Division of Infectious Diseases, and Immunology, Allergy, Saitama Children's Medical Center
Therapeutics
3:15 PM – 4:00 PM East Coast USA Time
24 - REDUCED CAPILLARY DENSITY IN THE MYOCARDIUM OF THE PATIENTS WITH KD HISTORY
37 - A MULTI-CENTER, NON-INFERIORITY STUDY TO EVALUATE THE EFFICACY OF ELIMINATION OF HIGH-DOSE ASPIRIN IN THE ACUTE STAGE OF KAWASAKI DISEASE FOR PREVENTING CORONARY ARTERY LESIONS (KIAA TRIAL)
43 - A PHASE I/IIA TRIAL OF ATROVASTATIN IN JAPANESE PATIENTS WITH ACUTE KAWASAKI DISEASE AND CORONARY ARTERY ANEURYSMS: A MULTICENTER, SINGLE-ARM, OPEN-LABEL TRIAL
Location: Outremont
Author: KENJI FURUNO, MD – Fukuoka Children's Hospital and Japanese Red Cross Fukuoka Hospital
Therapeutics
3:15 PM – 4:00 PM East Coast USA Time
55 - PATHOLOGICAL FEATURES OF CORONARY ARTERITIS SEQUALAE IN ADULTS WITH A HISTORY OF KAWASAKI DISEASE
Location: Outremont
Author: Yuki Yokouchi, MD, PhD – Department of pathology, Toho University Ohashi Medical Center
Etiology/Basic science
3:15 PM – 4:00 PM East Coast USA Time
59 - EVALUATING THE EFFICACY OF ESTABLISHED SCORES IN PREDICTING IVIG RESISTANCE IN INFANT KAWASAKI DISEASE
Location: Outremont
Author: Young Tae Lim, n/a – Department of Pediatrics, Kyungpook National University School of Medicine Hospital
Clinical Management
3:15 PM – 4:00 PM East Coast USA Time
66 - TIPS AND TRICKS FOR RADIATION OPTIMIZED COMPUTED TOMOGRAPHY ANGIOGRAPHY IN 298 CHILDREN WITH KD: OUR EXPERIENCE OVER 10 YEARS
Location: Outremont
Author: MANPHOOL SINGHAL, n/a – Postgraduate Institute of Medical Education and Research, Chandigarh, INDIA
Imaging
3:15 PM – 4:00 PM East Coast USA Time
78 - EARLY USE OF ADJUNCTIVE THERAPY TO REDUCE CORONARY ARTERY DAMAGE FROM KAWASAKI DISEASE IN HIGH-RISK INFANTS LESS THAN 6 MONTHS OF AGE: A TWO-CENTER EXPERIENCE
